Emerging data suggest this peptide, a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could represent a notable step forward for obesity management . https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026